Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

15th May 2017 08:00

RNS Number : 0635F
Mediclinic International plc
15 May 2017
 

Mediclinic International plc

(Incorporated in England and Wales)

Company Number 8338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

 

15 May 2017

 

 

Notification of Major Interest in Mediclinic International plc shares

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

MEDICLINIC INTERNATIONAL PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

PUBLIC INVESTMENT CORPORATION SOC LIMITED

4. Full name of shareholder(s)  (if different from 3.):

N/A

5. Date of the transaction and date onwhich the threshold is crossed orreached:

11 May 2017

6. Date on which issuer notified:

12 May 2017

7. Threshold(s) that is/are crossed orreached:

8%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

GB00B8HX8Z88

58 705 799

59 447 726

8.064%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

NONE

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

59 447 726

8.064%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

N/A

14. Contact name:

DEVILLIERS MAKONKO

15. Contact telephone number:

012 742 3578

 

Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South

Africa and on the NSX in Namibia.

 

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

[email protected]

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUABRBWAVAAR

Related Shares:

MDC.L
FTSE 100 Latest
Value8,774.65
Change-17.15